Carrier Screening Market by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Hematological Conditions, Neurological Conditions, Pulmonary Conditions), Technology, End-User - Global Forecast 2024-2030

Carrier Screening Market by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Hematological Conditions, Neurological Conditions, Pulmonary Conditions), Technology, End-User - Global Forecast 2024-2030


The Carrier Screening Market size was estimated at USD 3.07 billion in 2023 and expected to reach USD 3.52 billion in 2024, at a CAGR 14.93% to reach USD 8.13 billion by 2030.

Carrier screening is genetic testing conducted on individuals to determine whether they carry a gene for certain genetic disorders. As carriers, these individuals typically do not exhibit symptoms of the disorder; however, they can pass the gene on to their offspring, who may be at risk of inheriting the disease. Carrier screening is particularly recommended for individuals with a family history of genetic disorders or for those within certain ethnic groups that have a higher prevalence of specific genetic conditions. The increasing prevalence of inherited diseases, growing awareness among potential parents, and supportive government policies aimed at reducing the burden of genetic disorders increase the adoption of carrier screening. However, concerns associated with genetic data, the complexity of genetic counseling, and occasional false positives/negatives could lead to cumbersome follow-up testing and impending market growth. Nevertheless, the integration of next-generation sequencing (NGS) technologies, which allow for comprehensive screening of a large number of genetic conditions at once, the potential for growth in direct-to-consumer genetic testing services, and the expansion of carrier screening programs at the population level in various countries are expected to create potential opportunities for the market growth.

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of inherited diseases and focus on early disease detection and prevention
5.1.1.2. Rising geriatric population and high risk of chromosomal abnormalities
5.1.1.3. Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
5.1.2. Restraints
5.1.2.1. Dearth of skilled professionals and professional services
5.1.3. Opportunities
5.1.3.1. Emerging improvements in POC diagnostics
5.1.3.2. Technological advancements in carrier screening
5.1.4. Challenges
5.1.4.1. Presence of non-uniform standards and guidelines
5.2. Market Segmentation Analysis
5.2.1. Type: Expanded carrier screening (ECS) offers a wide overview of genetic health and conditions
5.2.2. End-User: Evolving application of carrier screening in hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Carrier Screening Market, by Type
6.1. Introduction
6.2. Expanded Carrier Screening
6.3. Targeted Disease Carrier Screening
7. Carrier Screening Market, by Medical Condition
7.1. Introduction
7.2. Hematological Conditions
7.3. Neurological Conditions
7.4. Pulmonary Conditions
8. Carrier Screening Market, by Technology
8.1. Introduction
8.2. DNA Sequencing
8.3. Microarrays
8.4. Polymerase Chain Reaction
9. Carrier Screening Market, by End-User
9.1. Introduction
9.2. Hospitals
9.3. Physician Offices & Clinics
9.4. Reference Laboratories
10. Americas Carrier Screening Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Carrier Screening Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Carrier Screening Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Invitae Completes Sale of Reproductive Health Assets to Natera
13.3.2. Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
13.3.3. Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
FIGURE 1. CARRIER SCREENING MARKET RESEARCH PROCESS
FIGURE 2. CARRIER SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARRIER SCREENING MARKET DYNAMICS
FIGURE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings